Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:17 am
| PEG Ratio | 12.64 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Unilever Ltd (HUL), a leader in the personal care industry, reported a market capitalization of ₹5,62,905 Cr with a share price of ₹2,396. The company has demonstrated a consistent upward trajectory in its revenue, with sales growing from ₹39,783 Cr in FY 2020 to ₹60,580 Cr in FY 2023. This trend continued into the trailing twelve months (TTM), where revenue stood at ₹64,243 Cr. Quarterly sales figures reveal a steady performance, with ₹15,623 Cr reported in September 2023, slightly increasing to ₹15,707 Cr in June 2024. HUL’s operational efficiency is reflected in its operating profit margin (OPM), which has consistently remained around 23-24% over the past year, indicating strong operational management. The company’s ability to maintain growth amid market fluctuations underscores its robust product portfolio and strategic market positioning.
Profitability and Efficiency Metrics
HUL’s profitability metrics reveal a solid financial performance, with a net profit of ₹10,926 Cr recorded in the most recent fiscal year. The company’s return on equity (ROE) stood at an impressive 20.7%, while the return on capital employed (ROCE) was reported at 27.8%. These figures indicate that HUL effectively utilizes its equity and capital to generate profits. The interest coverage ratio (ICR) of 40.17x highlights HUL’s strong ability to meet its interest obligations, suggesting low financial risk. Additionally, the company maintained a consistent net profit margin of around 16-17% over the last few years, reflecting its pricing power and cost management efficiency. However, the P/E ratio of 53.2 indicates that the stock is trading at a premium compared to many peers in the sector, which could imply overvaluation concerns among some investors.
Balance Sheet Strength and Financial Ratios
HUL’s balance sheet reflects a strong financial standing, with total assets amounting to ₹79,863 Cr as of March 2025. The company’s reserves have shown consistent growth, reaching ₹49,167 Cr, while borrowings increased to ₹1,648 Cr, indicating a prudent approach to leveraging debt. The company’s cash conversion cycle (CCC) remained efficient at -71 days, demonstrating effective management of working capital. The current ratio of 1.33 indicates that HUL has sufficient short-term assets to cover its liabilities, while the quick ratio of 1.07 further supports this assertion. The price-to-book value (P/BV) ratio of 10.75x suggests that the stock is valued highly relative to its book value, which may be a concern for value-focused investors. The company’s financial ratios indicate overall stability, but the high leverage in terms of P/BV could signal caution for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Unilever reveals a stable ownership structure, with promoters holding 61.90% of the company. This level of promoter holding indicates strong management commitment and alignment with shareholder interests. Foreign institutional investors (FIIs) have gradually reduced their stake from 14.32% in December 2022 to 10.79% in September 2025, while domestic institutional investors (DIIs) have increased their share from 11.50% to 15.62% over the same period. This shift suggests growing domestic confidence in HUL’s long-term prospects. The total number of shareholders stood at 10,95,447 in September 2025, reflecting a broad base of retail interest. Despite fluctuations in institutional investment, the overall stability in promoter holdings and increasing domestic institutional participation points towards a positive outlook for investor confidence in HUL’s future.
Outlook, Risks, and Final Insight
Looking ahead, Hindustan Unilever’s strong brand equity and diverse product range position it well to capitalize on growth opportunities in the personal care market. However, risks such as rising input costs and increased competition in the FMCG sector could impact margins. Additionally, the company’s relatively high valuation metrics, including a P/E ratio of 53.2 and a P/BV of 10.75x, may deter some value-oriented investors. Should HUL manage to sustain its growth trajectory while effectively navigating market challenges, it is likely to enhance shareholder value. Conversely, any significant downturn in consumer spending or adverse economic conditions could pose risks to its profitability. Overall, HUL’s fundamentals remain strong, but potential investors should weigh the inherent risks against the company’s growth prospects before making investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,449 Cr. | 290 | 334/190 | 75.9 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 44.2 Cr. | 25.7 | 37.0/23.3 | 86.7 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 115 Cr. | 120 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 592 Cr. | 390 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 9,570 Cr. | 261 | 423/259 | 26.2 | 55.8 | 1.34 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 70,694.00 Cr | 1,871.39 | 59.44 | 112.70 | 0.77% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15,144 | 15,597 | 15,215 | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,818 | 15,670 | 16,514 | 16,241 |
| Expenses | 11,665 | 11,903 | 11,643 | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 12,123 | 12,052 | 12,797 | 12,515 |
| Operating Profit | 3,479 | 3,694 | 3,572 | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,695 | 3,618 | 3,717 | 3,726 |
| OPM % | 23% | 24% | 23% | 24% | 24% | 24% | 23% | 24% | 24% | 23% | 23% | 23% | 23% |
| Other Income | 80 | 7 | 240 | 146 | 178 | 184 | 309 | 209 | 203 | 740 | 171 | 74 | 331 |
| Interest | 28 | 29 | 29 | 50 | 88 | 91 | 105 | 93 | 110 | 112 | 80 | 127 | 129 |
| Depreciation | 272 | 293 | 291 | 286 | 297 | 313 | 320 | 329 | 338 | 341 | 347 | 361 | 358 |
| Profit before tax | 3,259 | 3,379 | 3,492 | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,982 | 3,362 | 3,303 | 3,570 |
| Tax % | 18% | 27% | 26% | 26% | 26% | 27% | 25% | 26% | 27% | 25% | 26% | 16% | 25% |
| Net Profit | 2,670 | 2,481 | 2,601 | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 | 2,475 | 2,768 | 2,694 |
| EPS in Rs | 11.34 | 10.53 | 11.07 | 10.87 | 11.30 | 10.68 | 10.89 | 11.11 | 11.03 | 12.70 | 10.49 | 11.73 | 11.43 |
Last Updated: January 2, 2026, 6:03 pm
Below is a detailed analysis of the quarterly data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 16,241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16,514.00 Cr. (Jun 2025) to 16,241.00 Cr., marking a decrease of 273.00 Cr..
- For Expenses, as of Sep 2025, the value is 12,515.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12,797.00 Cr. (Jun 2025) to 12,515.00 Cr., marking a decrease of 282.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 3,726.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,717.00 Cr. (Jun 2025) to 3,726.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Sep 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 23.00%.
- For Other Income, as of Sep 2025, the value is 331.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Jun 2025) to 331.00 Cr., marking an increase of 257.00 Cr..
- For Interest, as of Sep 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 127.00 Cr. (Jun 2025) to 129.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 358.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 361.00 Cr. (Jun 2025) to 358.00 Cr., marking a decrease of 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 3,570.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,303.00 Cr. (Jun 2025) to 3,570.00 Cr., marking an increase of 267.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 16.00% (Jun 2025) to 25.00%, marking an increase of 9.00%.
- For Net Profit, as of Sep 2025, the value is 2,694.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,768.00 Cr. (Jun 2025) to 2,694.00 Cr., marking a decrease of 74.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 11.43. The value appears to be declining and may need further review. It has decreased from 11.73 (Jun 2025) to 11.43, marking a decrease of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29,234 | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 63,121 | 64,243 |
| Expenses | 24,475 | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 48,278 | 49,487 |
| Operating Profit | 4,759 | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,843 | 14,756 |
| OPM % | 16% | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% | 23% |
| Other Income | 792 | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,322 | 1,316 |
| Interest | 41 | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 395 | 448 |
| Depreciation | 296 | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,355 | 1,407 |
| Profit before tax | 5,215 | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,415 | 14,217 |
| Tax % | 24% | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | 26% | |
| Net Profit | 3,956 | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,671 | 10,926 |
| EPS in Rs | 18.24 | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.32 | 46.35 |
| Dividend Payout % | 71% | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% | 117% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.62% | -5.14% | 8.17% | 16.41% | 15.94% | 11.49% | 18.40% | 11.16% | 14.07% | 1.37% | 3.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.76% | 13.31% | 8.25% | -0.48% | -4.45% | 6.91% | -7.23% | 2.90% | -12.70% | 2.41% |
Hindustan Unilever Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 1% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 21% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,321 | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 49,167 | 48,481 |
| Borrowings | 46 | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,648 | 1,775 |
| Other Liabilities | 10,171 | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,813 | 31,543 |
| Total Liabilities | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
| Fixed Assets | 2,746 | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,335 | 58,126 |
| CWIP | 373 | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,009 | 1,022 |
| Investments | 2,838 | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 3,810 | 3,958 |
| Other Assets | 7,797 | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 20,709 | 18,928 |
| Total Assets | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
Below is a detailed analysis of the balance sheet data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 235.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 235.00 Cr..
- For Reserves, as of Sep 2025, the value is 48,481.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49,167.00 Cr. (Mar 2025) to 48,481.00 Cr., marking a decrease of 686.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,775.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,648.00 Cr. (Mar 2025) to 1,775.00 Cr., marking an increase of 127.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 31,543.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28,813.00 Cr. (Mar 2025) to 31,543.00 Cr., marking an increase of 2,730.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 82,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 58,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 54,335.00 Cr. (Mar 2025) to 58,126.00 Cr., marking an increase of 3,791.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,022.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,009.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 3,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,810.00 Cr. (Mar 2025) to 3,958.00 Cr., marking an increase of 148.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18,928.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,709.00 Cr. (Mar 2025) to 18,928.00 Cr., marking a decrease of 1,781.00 Cr..
- For Total Assets, as of Sep 2025, the value is 82,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
Notably, the Reserves (48,481.00 Cr.) exceed the Borrowings (1,775.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -38.00 | -172.00 | -271.00 | 7.00 | -91.00 | 9.00 | 11.00 | 11.00 | 13.00 | 13.00 | 13.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13 | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 | 22 |
| Inventory Days | 86 | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 | 59 |
| Days Payable | 170 | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 | 152 |
| Cash Conversion Cycle | -72 | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 | -71 |
| Working Capital Days | -54 | -53 | -26 | -35 | -37 | -30 | -31 | -32 | -22 | -15 | -22 | -33 |
| ROCE % | 147% | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% | 28% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Value Fund | 5,507,635 | 2.25 | 1358.51 | N/A | N/A | N/A |
| Nippon India Large Cap Fund | 5,035,752 | 2.47 | 1242.12 | N/A | N/A | N/A |
| SBI Large Cap Fund | 4,590,000 | 2.03 | 1132.17 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 3,225,560 | 1.06 | 795.62 | 3,210,976 | 2025-12-15 00:05:18 | 0.45% |
| ICICI Prudential India Opportunities Fund | 2,786,872 | 2.02 | 687.41 | N/A | N/A | N/A |
| Kotak Flexicap Fund | 2,600,000 | 1.13 | 641.32 | N/A | N/A | N/A |
| Mirae Asset Large Cap Fund | 2,303,345 | 1.36 | 568.14 | 2,315,497 | 2025-12-08 01:09:48 | -0.52% |
| Nippon India Small Cap Fund | 2,121,461 | 0.76 | 523.28 | N/A | N/A | N/A |
| ICICI Prudential Equity Savings Fund | 2,027,071 | 2.85 | 500 | N/A | N/A | N/A |
| SBI Large & Midcap Fund | 2,000,000 | 1.33 | 493.32 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Diluted EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Cash EPS (Rs.) | 51.21 | 48.94 | 48.00 | 42.48 | 38.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Revenue From Operations / Share (Rs.) | 268.60 | 263.39 | 257.79 | 223.17 | 200.12 |
| PBDIT / Share (Rs.) | 67.52 | 65.85 | 62.39 | 55.81 | 51.22 |
| PBIT / Share (Rs.) | 61.76 | 60.67 | 57.55 | 51.17 | 46.65 |
| PBT / Share (Rs.) | 61.37 | 59.28 | 56.79 | 50.53 | 45.13 |
| Net Profit / Share (Rs.) | 45.44 | 43.77 | 43.17 | 37.84 | 34.04 |
| NP After MI And SOA / Share (Rs.) | 45.31 | 43.73 | 43.06 | 37.78 | 34.02 |
| PBDIT Margin (%) | 25.13 | 25.00 | 24.20 | 25.00 | 25.59 |
| PBIT Margin (%) | 22.99 | 23.03 | 22.32 | 22.92 | 23.30 |
| PBT Margin (%) | 22.84 | 22.50 | 22.03 | 22.64 | 22.55 |
| Net Profit Margin (%) | 16.91 | 16.61 | 16.74 | 16.95 | 17.00 |
| NP After MI And SOA Margin (%) | 16.87 | 16.60 | 16.70 | 16.92 | 17.00 |
| Return on Networth / Equity (%) | 21.55 | 20.06 | 20.11 | 18.09 | 16.77 |
| Return on Capital Employeed (%) | 22.91 | 21.72 | 22.14 | 20.29 | 19.01 |
| Return On Assets (%) | 13.33 | 13.09 | 13.84 | 12.59 | 11.62 |
| Asset Turnover Ratio (%) | 0.79 | 0.81 | 0.83 | 0.73 | 1.04 |
| Current Ratio (X) | 1.33 | 1.66 | 1.41 | 1.38 | 1.28 |
| Quick Ratio (X) | 1.07 | 1.34 | 1.06 | 1.01 | 0.95 |
| Inventory Turnover Ratio (X) | 14.96 | 14.96 | 4.73 | 4.25 | 4.86 |
| Dividend Payout Ratio (NP) (%) | 116.94 | 91.44 | 83.58 | 84.68 | 110.20 |
| Dividend Payout Ratio (CP) (%) | 103.74 | 81.77 | 75.14 | 75.41 | 97.15 |
| Earning Retention Ratio (%) | -16.94 | 8.56 | 16.42 | 15.32 | -10.20 |
| Cash Earning Retention Ratio (%) | -3.74 | 18.23 | 24.86 | 24.59 | 2.85 |
| Interest Coverage Ratio (X) | 40.17 | 46.33 | 128.61 | 123.73 | 102.87 |
| Interest Coverage Ratio (Post Tax) (X) | 27.26 | 31.78 | 90.55 | 85.25 | 71.42 |
| Enterprise Value (Cr.) | 523601.25 | 525697.75 | 596944.25 | 477659.75 | 566787.00 |
| EV / Net Operating Revenue (X) | 8.30 | 8.49 | 9.85 | 9.11 | 12.05 |
| EV / EBITDA (X) | 33.00 | 33.97 | 40.72 | 36.42 | 47.09 |
| MarketCap / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| Retention Ratios (%) | -16.94 | 8.55 | 16.41 | 15.31 | -10.20 |
| Price / BV (X) | 10.75 | 10.41 | 11.95 | 9.81 | 11.98 |
| Price / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Hindustan Unilever Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Cash EPS (Rs.), as of Mar 25, the value is 51.21. This value is within the healthy range. It has increased from 48.94 (Mar 24) to 51.21, marking an increase of 2.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.60. It has increased from 263.39 (Mar 24) to 268.60, marking an increase of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 67.52. This value is within the healthy range. It has increased from 65.85 (Mar 24) to 67.52, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 61.76. This value is within the healthy range. It has increased from 60.67 (Mar 24) to 61.76, marking an increase of 1.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 61.37. This value is within the healthy range. It has increased from 59.28 (Mar 24) to 61.37, marking an increase of 2.09.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 45.44. This value is within the healthy range. It has increased from 43.77 (Mar 24) to 45.44, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.31. This value is within the healthy range. It has increased from 43.73 (Mar 24) to 45.31, marking an increase of 1.58.
- For PBDIT Margin (%), as of Mar 25, the value is 25.13. This value is within the healthy range. It has increased from 25.00 (Mar 24) to 25.13, marking an increase of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 22.99. This value exceeds the healthy maximum of 20. It has decreased from 23.03 (Mar 24) to 22.99, marking a decrease of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 22.84. This value is within the healthy range. It has increased from 22.50 (Mar 24) to 22.84, marking an increase of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 10. It has increased from 16.61 (Mar 24) to 16.91, marking an increase of 0.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 16.60 (Mar 24) to 16.87, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.55. This value is within the healthy range. It has increased from 20.06 (Mar 24) to 21.55, marking an increase of 1.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 21.72 (Mar 24) to 22.91, marking an increase of 1.19.
- For Return On Assets (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 13.09 (Mar 24) to 13.33, marking an increase of 0.24.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.66 (Mar 24) to 1.33, marking a decrease of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.07, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.96. This value exceeds the healthy maximum of 8. There is no change compared to the previous period (Mar 24) which recorded 14.96.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 116.94. This value exceeds the healthy maximum of 50. It has increased from 91.44 (Mar 24) to 116.94, marking an increase of 25.50.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 103.74. This value exceeds the healthy maximum of 50. It has increased from 81.77 (Mar 24) to 103.74, marking an increase of 21.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 40. It has decreased from 8.56 (Mar 24) to -16.94, marking a decrease of 25.50.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 40. It has decreased from 18.23 (Mar 24) to -3.74, marking a decrease of 21.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 40.17. This value is within the healthy range. It has decreased from 46.33 (Mar 24) to 40.17, marking a decrease of 6.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.26. This value is within the healthy range. It has decreased from 31.78 (Mar 24) to 27.26, marking a decrease of 4.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 523,601.25. It has decreased from 525,697.75 (Mar 24) to 523,601.25, marking a decrease of 2,096.50.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 3. It has decreased from 8.49 (Mar 24) to 8.30, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 33.00. This value exceeds the healthy maximum of 15. It has decreased from 33.97 (Mar 24) to 33.00, marking a decrease of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For Retention Ratios (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 30. It has decreased from 8.55 (Mar 24) to -16.94, marking a decrease of 25.49.
- For Price / BV (X), as of Mar 25, the value is 10.75. This value exceeds the healthy maximum of 3. It has increased from 10.41 (Mar 24) to 10.75, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Unilever Ltd:
- Net Profit Margin: 16.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.91% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.55% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 52.7 (Industry average Stock P/E: 59.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Unilever House, B D Sawant Marg, Mumbai Maharashtra 400099 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nitin Paranjpe | Chairman & Non-Exe.Director |
| Mr. Rohit Jawa | Managing Director & CEO |
| Mr. Ritesh Tiwari | Executive Director & CFO |
| Mr. Leo Puri | Independent Director |
| Ms. Ashu Suyash | Independent Director |
| Mr. Ranjay Gulati | Independent Director |
| Ms. Neelam Dhawan | Independent Director |
| Mr. Tarun Bajaj | Independent Director |
| Mr. Biddappa Ponnappa Bittianda | Executive Director |
FAQ
What is the intrinsic value of Hindustan Unilever Ltd?
Hindustan Unilever Ltd's intrinsic value (as of 11 January 2026) is ₹1839.21 which is 22.49% lower the current market price of ₹2,373.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,57,464 Cr. market cap, FY2025-2026 high/low of ₹2,660/2,044, reserves of ₹48,481 Cr, and liabilities of ₹82,034 Cr.
What is the Market Cap of Hindustan Unilever Ltd?
The Market Cap of Hindustan Unilever Ltd is 5,57,464 Cr..
What is the current Stock Price of Hindustan Unilever Ltd as on 11 January 2026?
The current stock price of Hindustan Unilever Ltd as on 11 January 2026 is ₹2,373.
What is the High / Low of Hindustan Unilever Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Unilever Ltd stocks is ₹2,660/2,044.
What is the Stock P/E of Hindustan Unilever Ltd?
The Stock P/E of Hindustan Unilever Ltd is 52.7.
What is the Book Value of Hindustan Unilever Ltd?
The Book Value of Hindustan Unilever Ltd is 207.
What is the Dividend Yield of Hindustan Unilever Ltd?
The Dividend Yield of Hindustan Unilever Ltd is 1.81 %.
What is the ROCE of Hindustan Unilever Ltd?
The ROCE of Hindustan Unilever Ltd is 27.8 %.
What is the ROE of Hindustan Unilever Ltd?
The ROE of Hindustan Unilever Ltd is 20.7 %.
What is the Face Value of Hindustan Unilever Ltd?
The Face Value of Hindustan Unilever Ltd is 1.00.